2022 Q3 Form 10-Q Financial Statement

#000149315222022763 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $330.2K $418.2K $254.7K
YoY Change 40.84% 246.15% 73.84%
Cost Of Revenue $225.9K $179.7K $78.96K
YoY Change -266.62% -53.35% -72.66%
Gross Profit $104.2K $206.8K $175.7K
YoY Change -71.83% -178.24% -223.47%
Gross Profit Margin 31.57% 49.45% 69.0%
Selling, General & Admin $824.4K $830.4K $730.0K
YoY Change -49.27% -54.57% 0.02%
% of Gross Profit 790.96% 401.57% 415.4%
Research & Development $5.390K $2.738K $16.59K
YoY Change 72.76% -24.72% 4265.79%
% of Gross Profit 5.17% 1.32% 9.44%
Depreciation & Amortization $3.770K $6.640K $5.100K
YoY Change -26.08% 30.2% 0.0%
% of Gross Profit 3.62% 3.21% 2.9%
Operating Expenses $833.6K $839.8K $751.7K
YoY Change -48.96% -54.28% 2.22%
Operating Profit -$729.4K -$633.0K -$575.9K
YoY Change -42.26% -69.87% -34.38%
Interest Expense $12.17M $450.3K -$2.311M
YoY Change -2758.62% 96.92% 356.83%
% of Operating Profit
Other Income/Expense, Net $66.35K -$10.58M
YoY Change 3362.11%
Pretax Income $11.51M -$11.21M -$2.779M
YoY Change -706.28% 365.89% 96.65%
Income Tax
% Of Pretax Income
Net Earnings $11.51M -$11.21M -$2.779M
YoY Change -706.28% 365.89% 96.65%
Net Earnings / Revenue 3485.9% -2681.17% -1091.17%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share $0.02 -$22.21K -$5.613K
COMMON SHARES
Basic Shares Outstanding 523.1M shares 504.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $365.2K $6.980K $26.58K
YoY Change 1086.09% -68.36% -65.49%
Cash & Equivalents $365.2K $6.560K
Short-Term Investments $420.00
Other Short-Term Assets $279.6K $59.56K $25.70K
YoY Change 571.21% 449.95% -95.52%
Inventory $777.9K $924.5K $952.1K
Prepaid Expenses $279.6K $59.56K
Receivables $256.1K $235.8K $58.14K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.679M $1.226M $1.063M
YoY Change 62.34% 19.61% -33.54%
LONG-TERM ASSETS
Property, Plant & Equipment $28.01K $31.77K $439.5K
YoY Change -93.77% -87.73% -8.23%
Goodwill $9.807M
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M $420.00 $420.00
YoY Change 20065.52% -95.77% -95.77%
Other Assets $0.00 $250.0K $250.0K
YoY Change -100.0% -45.03% 9.28%
Total Long-Term Assets $3.545M $298.4K $706.1K
YoY Change 388.36% -59.67% -3.77%
TOTAL ASSETS
Total Short-Term Assets $1.679M $1.226M $1.063M
Total Long-Term Assets $3.545M $298.4K $706.1K
Total Assets $5.223M $1.525M $1.769M
YoY Change 196.8% -13.62% -24.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.253M $1.929M $1.540M
YoY Change 120.81% 178.75% 326.45%
Accrued Expenses $19.76K $29.02K $2.558M
YoY Change -54.55% -99.13% -16.53%
Deferred Revenue $15.18K $15.18K
YoY Change -58.64%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $6.571M $7.290M $7.604M
YoY Change -1.24% 10.7% 38.17%
Total Short-Term Liabilities $10.01M $24.78M $15.14M
YoY Change -12.93% 83.13% 23.21%
LONG-TERM LIABILITIES
Long-Term Debt $3.366M $156.9K $248.2K
YoY Change 1256.03% -62.03% -39.94%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.366M $156.9K $248.2K
YoY Change 1256.03% -62.03% -39.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.01M $24.78M $15.14M
Total Long-Term Liabilities $3.366M $156.9K $248.2K
Total Liabilities $13.38M $24.93M $15.39M
YoY Change 13.89% 78.83% 21.16%
SHAREHOLDERS EQUITY
Retained Earnings -$43.64M -$55.15M
YoY Change 10.45%
Common Stock $50.14K $52.20K
YoY Change 3.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.155M -$23.41M -$13.62M
YoY Change
Total Liabilities & Shareholders Equity $5.223M $1.525M $1.769M
YoY Change 196.8% -13.62% -24.17%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $11.51M -$11.21M -$2.779M
YoY Change -706.28% 365.89% 96.65%
Depreciation, Depletion And Amortization $3.770K $6.640K $5.100K
YoY Change -26.08% 30.2% 0.0%
Cash From Operating Activities -$235.9K -$106.7K -$174.7K
YoY Change -59.06% -90.28% -79.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.500M $0.00 $9.500K
YoY Change
Cash From Investing Activities -$1.500M $0.00 $9.500K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.095M 86.65K 0.000
YoY Change 264.26% -91.69% -100.0%
NET CHANGE
Cash From Operating Activities -235.9K -106.7K -174.7K
Cash From Investing Activities -1.500M 0.000 9.500K
Cash From Financing Activities 2.095M 86.65K 0.000
Net Change In Cash 358.6K -20.01K -165.2K
YoY Change -30234.45% -63.59% -1302.4%
FREE CASH FLOW
Cash From Operating Activities -$235.9K -$106.7K -$174.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001109486
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q2 EDXC Inventory Impairment
InventoryImpairment
usd
CY2021Q2 EDXC Default Penalties
DefaultPenalties
usd
CY2022Q2 EDXC Gain From Settlement Of Derivative Liability
GainFromSettlementOfDerivativeLiability
usd
CY2021Q2 EDXC Gain From Settlement Of Derivative Liability
GainFromSettlementOfDerivativeLiability
usd
EDXC Gain From Settlement Of Derivative Liability
GainFromSettlementOfDerivativeLiability
usd
CY2021Q2 EDXC Gain On Settlement Of Liabilities
GainOnSettlementOfLiabilities
usd
EDXC Gain On Settlement Of Liabilities
GainOnSettlementOfLiabilities
usd
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2020Q4 EDXC Stock Issued During Period Value For Settlement Of Preferred Stock
StockIssuedDuringPeriodValueForSettlementOfPreferredStock
usd
CY2021Q4 EDXC Stock Issued During Period Value For Private Placements
StockIssuedDuringPeriodValueForPrivatePlacements
usd
EDXC Warrants Issued For Financing Costs
WarrantsIssuedForFinancingCosts
usd
EDXC Gain From Settlement Of Liabilities
GainFromSettlementOfLiabilities
usd
EDXC Gain From Settlement Of Derivative Liabilities
GainFromSettlementOfDerivativeLiabilities
usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
EDXC Increase Decreasein Accrued Interest Related Party
IncreaseDecreaseinAccruedInterestRelatedParty
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
EDXC Derivative Liability Settled Through Conversion Of Convertible Notes
DerivativeLiabilitySettledThroughConversionOfConvertibleNotes
usd
EDXC Prepaid Expenses From Note Payable
PrepaidExpensesFromNotePayable
usd
EDXC Accrued Interest Settled Through Note Payable
AccruedInterestSettledThroughNotePayable
usd
EDXC Property And Equipment Net Sold For Settlement Of Convertible Note And Interest Payable
PropertyAndEquipmentNetSoldForSettlementOfConvertibleNoteAndInterestPayable
usd
EDXC Convertible Notes And Interest Payable Settled Through Sale Of Property And Equipment
ConvertibleNotesAndInterestPayableSettledThroughSaleOfPropertyAndEquipment
usd
EDXC Amortization Of Rightofuse Asset And Lease Liability
AmortizationOfRightofuseAssetAndLeaseLiability
usd
us-gaap Notes Issued1
NotesIssued1
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercise Weightedaverage Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExerciseWeightedaverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired Weightedaverage Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredWeightedaverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-30233
dei Entity Registrant Name
EntityRegistrantName
Endexx Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0353162
dei Entity Address Address Line1
EntityAddressAddressLine1
38246 North Hazelwood Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Cave Creek
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85331
dei City Area Code
CityAreaCode
(480)
dei Local Phone Number
LocalPhoneNumber
595-6900
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
523050912 shares
CY2022Q2 us-gaap Cash
Cash
6560 usd
CY2021Q3 us-gaap Cash
Cash
20867 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
58257 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
58257 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
235764 usd
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
50755 usd
CY2022Q2 us-gaap Inventory Adjustments
InventoryAdjustments
952749 usd
CY2021Q3 us-gaap Inventory Adjustments
InventoryAdjustments
1001542 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
924468 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
920812 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59560 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41648 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1226352 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1034082 usd
CY2022Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
420 usd
CY2021Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
9920 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73276 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75388 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31773 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449661 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
250000 usd
CY2021Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
250000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16250 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16250 usd
CY2022Q2 us-gaap Assets
Assets
1524795 usd
CY2021Q3 us-gaap Assets
Assets
1759913 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1929253 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1020464 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15182 usd
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
36705 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29021 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43469 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1554834 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1095248 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1114253 usd
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
849919 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
78290 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
10957 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1412737 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1201584 usd
CY2022Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
5877582 usd
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
5452111 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12843580 usd
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1799354 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
24776442 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11498854 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
156900 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
248200 usd
CY2022Q2 us-gaap Liabilities
Liabilities
24933342 usd
CY2021Q3 us-gaap Liabilities
Liabilities
11747054 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
521988324 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
521988324 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
486313058 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
486313058 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
52199 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
48631 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31690482 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29477818 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55151482 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39513844 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-23408547 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-9987141 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1524795 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1759913 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
418151 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120801 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
947428 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
416094 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
179650 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
385097 usd
us-gaap Cost Of Revenue
CostOfRevenue
489029 usd
us-gaap Cost Of Revenue
CostOfRevenue
724650 usd
CY2022Q2 EDXC Inventory Impairment
InventoryImpairment
31709 usd
EDXC Inventory Impairment
InventoryImpairment
59622 usd
EDXC Inventory Impairment
InventoryImpairment
228290 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
206792 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
-264296 usd
us-gaap Gross Profit
GrossProfit
398777 usd
us-gaap Gross Profit
GrossProfit
-536846 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6638 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5100 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16838 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15300 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
94311 usd
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1085311 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
444255 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1444600 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
161317 usd
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
166908 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
479684 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
469629 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
405015 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
355410 usd
us-gaap Professional Fees
ProfessionalFees
1442346 usd
us-gaap Professional Fees
ProfessionalFees
777317 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2738 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3637 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21675 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7021 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
169766 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
220236 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
626864 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
680199 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
839785 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1836602 usd
us-gaap Operating Expenses
OperatingExpenses
3031662 usd
us-gaap Operating Expenses
OperatingExpenses
3394066 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-632993 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2100898 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2632885 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3930912 usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-9424041 usd
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
440417 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-11044226 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
240216 usd
CY2022Q2 EDXC Financing Costs And Discount Amortization
FinancingCostsAndDiscountAmortization
543230 usd
CY2021Q2 EDXC Financing Costs And Discount Amortization
FinancingCostsAndDiscountAmortization
517303 usd
EDXC Financing Costs And Discount Amortization
FinancingCostsAndDiscountAmortization
1093823 usd
EDXC Financing Costs And Discount Amortization
FinancingCostsAndDiscountAmortization
1271727 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
450287 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
228660 usd
us-gaap Interest Expense
InterestExpense
928664 usd
us-gaap Interest Expense
InterestExpense
721021 usd
CY2022Q2 EDXC Default Penalties
DefaultPenalties
584738 usd
EDXC Default Penalties
DefaultPenalties
584738 usd
EDXC Default Penalties
DefaultPenalties
91576 usd
EDXC Gain From Settlement Of Derivative Liability
GainFromSettlementOfDerivativeLiability
865103 usd
EDXC Gain On Settlement Of Liabilities
GainOnSettlementOfLiabilities
222748 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
423950 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
423950 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10578346 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-305546 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13004753 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-979005 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11211339 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2406444 usd
us-gaap Net Income Loss
NetIncomeLoss
-15637638 usd
us-gaap Net Income Loss
NetIncomeLoss
-4909917 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
504758044 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
460035302 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
500181299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
445401099 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-11653972 usd
CY2020Q4 EDXC Stock Issued During Period Value For Private Placements
StockIssuedDuringPeriodValueForPrivatePlacements
203000 usd
CY2020Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25860 usd
CY2020Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
758685 usd
CY2020Q4 EDXC Adjustments To Additional Paid In Capital Settlement Of Derivative Liability
AdjustmentsToAdditionalPaidInCapitalSettlementOfDerivativeLiability
1420444 usd
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1090227 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-10336210 usd
CY2021Q1 EDXC Stock Issued During Period Value For Private Placements
StockIssuedDuringPeriodValueForPrivatePlacements
25000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1358400 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1413246 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-10366056 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
117333 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
477560 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2406444 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-12177607 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-9987141 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
135813 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
360906 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1647205 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-10837627 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2779094 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-13616721 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
155800 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
294643 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
162332 usd
CY2022Q2 EDXC Stock Issued During Period Value Conversion Of Interest
StockIssuedDuringPeriodValueConversionOfInterest
222000 usd
CY2022Q2 EDXC Stock Issued During Period Value For Default Penalty
StockIssuedDuringPeriodValueForDefaultPenalty
584738 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11211339 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-23408547 usd
us-gaap Net Income Loss
NetIncomeLoss
-15637638 usd
us-gaap Net Income Loss
NetIncomeLoss
-4909917 usd
us-gaap Share Based Compensation
ShareBasedCompensation
455800 usd
us-gaap Share Based Compensation
ShareBasedCompensation
143193 usd
EDXC Shares Issued For Financing Costs
SharesIssuedForFinancingCosts
430456 usd
EDXC Shares Issued For Financing Costs
SharesIssuedForFinancingCosts
477560 usd
EDXC Warrants Issued For Financing Costs
WarrantsIssuedForFinancingCosts
523238 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16838 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15300 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
105447 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
662477 usd
EDXC Gain Loss On Derivative Instruments Net Pretax.
GainLossOnDerivativeInstrumentsNetPretax.
-11044226 usd
EDXC Gain Loss On Derivative Instruments Net Pretax.
GainLossOnDerivativeInstrumentsNetPretax.
240216 usd
EDXC Gain From Settlement Of Liabilities
GainFromSettlementOfLiabilities
222748 usd
EDXC Gain From Settlement Of Derivative Liabilities
GainFromSettlementOfDerivativeLiabilities
865103 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
423950 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
59622 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
228290 usd
EDXC Financing Costs
FinancingCosts
34682 usd
EDXC Financing Costs
FinancingCosts
131690 usd
EDXC Default Penalty
DefaultPenalty
584738 usd
EDXC Default Penalty
DefaultPenalty
91576 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
185009 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37152 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63278 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44424 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-42088 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11271 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
908789 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
271615 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-21523 usd
EDXC Increase Decreasein Accrued Interest Related Party
IncreaseDecreaseinAccruedInterestRelatedParty
64332 usd
EDXC Increase Decrease In Payroll And Taxes Payable Primarily Related Party
IncreaseDecreaseInPayrollAndTaxesPayablePrimarilyRelatedParty
264334 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
41137 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14448 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-19235 usd
EDXC Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
871053 usd
EDXC Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
615369 usd
EDXC Increase Decrease In Payroll And Taxes Payable Primarily Related Party
IncreaseDecreaseInPayrollAndTaxesPayablePrimarilyRelatedParty
240704 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1227283 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3144075 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9500 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
228000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
999853 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1614234 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
203623 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1340000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20750 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1203476 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3161484 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14307 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17409 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20867 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4650 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6560 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22059 usd
us-gaap Interest Paid Net
InterestPaidNet
57611 usd
us-gaap Interest Paid Net
InterestPaidNet
41320 usd
EDXC Convertible Notes And Interest Converted To Common Stock
ConvertibleNotesAndInterestConvertedToCommonStock
222000 usd
EDXC Convertible Notes And Interest Converted To Common Stock
ConvertibleNotesAndInterestConvertedToCommonStock
758685 usd
EDXC Derivative Liability Settled Through Conversion Of Convertible Notes
DerivativeLiabilitySettledThroughConversionOfConvertibleNotes
1420444 usd
EDXC Debt Discount At Origination
DebtDiscountAtOrigination
213420 usd
EDXC Debt Discount At Origination
DebtDiscountAtOrigination
68100 usd
EDXC Prepaid Expenses From Note Payable
PrepaidExpensesFromNotePayable
60000 usd
EDXC Accrued Interest Settled Through Note Payable
AccruedInterestSettledThroughNotePayable
7107 usd
EDXC Property And Equipment Net Sold For Settlement Of Convertible Note And Interest Payable
PropertyAndEquipmentNetSoldForSettlementOfConvertibleNoteAndInterestPayable
401050 usd
EDXC Convertible Notes And Interest Payable Settled Through Sale Of Property And Equipment
ConvertibleNotesAndInterestPayableSettledThroughSaleOfPropertyAndEquipment
825000 usd
EDXC Amortization Of Rightofuse Asset And Lease Liability
AmortizationOfRightofuseAssetAndLeaseLiability
30000 usd
us-gaap Notes Issued1
NotesIssued1
1057976 usd
CY2022Q2 EDXC Working Capital Deficit
WorkingCapitalDeficit
-23550090 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55151482 usd
us-gaap Net Income Loss
NetIncomeLoss
-15637638 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1227283 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_ziTuU1pMhF5l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zP2BMJg3ds1">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statement preparation requires that management make estimates and assumptions which affect the reporting of assets and liabilities and the related disclosure of contingent assets and liabilities in order to report these financial statements in conformity with GAAP. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
58257 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
58257 usd
CY2022Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
309560 usd
CY2021Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
291648 usd
EDXC Schedule Of Property And Equipment Useful Lives
ScheduleOfPropertyAndEquipmentUsefulLives
<p id="xdx_89C_ecustom--ScheduleOfPropertyAndEquipmentUsefulLives_zWHBCgkYzOkl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is computed on the straight-line method net of salvage value with useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zLolaRuqMUr1" style="display: none">Schedule of Property and Equipment Useful Lives</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"> <td style="font-family: Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment and software</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dt_c20211001__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zKA9cyFbfhca" title="Useful lives property and equipment">5 years</span></span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business equipment and fixtures</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dt_c20211001__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BusinessEquipmentandFixturesMember_zih50ifI9fKc" title="Useful lives property and equipment">7 years</span></span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and buildings</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dt_c20211001__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PropertyandBuildingsMember_zfAIhgbRkskk" title="Useful lives property and equipment">39 years</span></span></td></tr> </table>
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
418151 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120801 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
947428 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
416094 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
420 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
12843580 usd
CY2022Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
12844000 usd
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
9920 usd
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
1799354 usd
CY2021Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
1809274 usd
CY2021Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
1799354 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
11044226 usd
CY2022Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
12843580 usd
CY2022Q2 us-gaap Inventory Adjustments
InventoryAdjustments
952749 usd
CY2021Q3 us-gaap Inventory Adjustments
InventoryAdjustments
1001542 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21675 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7021 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
645740908 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
159750018 shares
EDXC Percentage For Beneficial Ownership Limitation Cap
PercentageForBeneficialOwnershipLimitationCap
0.0499 pure
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
394950 usd
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
410569 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1281036 usd
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1187096 usd
CY2022Q2 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
105045 usd
CY2021Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
224147 usd
CY2022Q2 EDXC Inventory Apparel
InventoryApparel
96186 usd
CY2021Q3 EDXC Inventory Apparel
InventoryApparel
100542 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
924468 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
920812 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
105049 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
525049 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73276 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75388 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31773 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449661 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
180000 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
423950 usd
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1647927 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
78290 usd
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1460741 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
10957 usd
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
199074 usd
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
105403 usd
CY2022Q2 EDXC Derivative Liability Balances Related To Accrued Interest
DerivativeLiabilityBalancesRelatedToAccruedInterest
3733510 usd
CY2021Q3 EDXC Derivative Liability Balances Related To Accrued Interest
DerivativeLiabilityBalancesRelatedToAccruedInterest
357154 usd
CY2022Q2 EDXC Accrued Officer Salaries Current
AccruedOfficerSalariesCurrent
212761 usd
CY2021Q3 EDXC Accrued Officer Salaries Current
AccruedOfficerSalariesCurrent
95761 usd
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
128105 usd
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
128105 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
773387 usd
CY2021Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
626053 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1114253 usd
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
849919 usd
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
521988324 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
521988324 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
486313058 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
486313058 shares
CY2021Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
6211180 shares
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
4100000 shares
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
155800 usd
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
20750000 shares
CY2019Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P4Y
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
187500 shares
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7587 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.08
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
10288066 shares
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
353319 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.06
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5000000 shares
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
162332 usd
CY2022Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.06
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
20750000 shares
CY2021Q3 EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weightedaverage Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedaverageExercisePrice
0.12
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeOutstanding
P1Y4M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
36225566 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
15475566 shares
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weightedaverage Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedaverageExercisePrice
0.06
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeGranted
P5Y
CY2022Q2 EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weightedaverage Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedaverageExercisePrice
0.09
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Outstanding Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeOutstandingEnding
P2Y3M18D
CY2022Q2 EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Execisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExecisableNumber
36225566 shares
CY2022Q2 EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weightedaverage Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedaverageExercisePrice
0.09
EDXC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeExercisable
P2Y3M18D
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
6250000 usd
CY2022Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
100000000 usd
CY2019Q1 us-gaap Collaborative Arrangement Rights And Obligations
CollaborativeArrangementRightsAndObligations
we entered into an agreement with a third party to represent our products to customers, the term of the agreement is for four (4) years from the date of the contract, January 28, 2023, and has automatic four-year renewal clauses. We agreed to pay a commission of nineteen percent (19%), composed of ten percent (10%) for commission, two percent (2%) for override, and seven percent (7%) for expenses of managing and advertising the account. Within thirty (30) days of the end of the calendar year, we agreed to pay the representative a bonus for certain sales milestones if two percent (2%) of the net receipts, payable in shares of our restricted common stock
us-gaap Collaborative Arrangement Rights And Obligations
CollaborativeArrangementRightsAndObligations
From time to time, we enter into consulting agreements for our products to be represented to certain customers or geographic areas. The terms of these agreements range from one (1) to five (5) years, and some include automatic one-year renewal clauses. As part of the agreement, commissions of ten percent (10%) are paid for sales with no distributor involved, and commissions of seven percent (7%) are paid for sales with a distributor. Depending on the consultant’s performance and achievement of certain milestones, the Company also may issue a stock bonus
us-gaap Payments For Rent
PaymentsForRent
3250 usd
CY2022Q2 EDXC Percentage Of Escalate In Lease Payments
PercentageOfEscalateInLeasePayments
0.03 pure
CY2022Q2 EDXC Gain On Settlement Of Liabilities
GainOnSettlementOfLiabilities
usd

Files In Submission

Name View Source Status
R19.htm Edgar Link pending
0001493152-22-022763-index-headers.html Edgar Link pending
0001493152-22-022763-index.html Edgar Link pending
0001493152-22-022763.txt Edgar Link pending
0001493152-22-022763-xbrl.zip Edgar Link pending
edxc-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
edxc-20220630_pre.xml Edgar Link unprocessable
edxc-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
edxc-20220630_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
edxc-20220630_cal.xml Edgar Link unprocessable